Center-Authored Papers

Filters: Author is Maier, Christiane  [Clear All Filters]
A
Al Olama AA, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal D, Hamdy FC, Donovan JL, Muir K, Schleutker J et al..  2015.  Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(19):5589-602. Abstract
Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E et al..  2014.  A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.. Nature genetics. 46(10):1103-9. Abstract
Al Olama AA, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S et al..  2015.  Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.. Human molecular genetics. 24(19):5589-5602. Abstract
Al Olama AA, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC et al..  2013.  A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.. Human molecular genetics. 22(2):408-15. Abstract
B
Bailey-Wilson JE, Childs EJ, Cropp CD, Schaid DJ, Xu J, Camp NJ, Cannon-Albright LA, Farnham JM, George A, Powell I et al..  2012.  Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.. BMC medical genetics. 13(1):46. Abstract
Bonilla C, Lewis SJ, Martin RM, Donovan JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA et al..  2016.  Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort.. BMC medicine. 14(1):66. Abstract
Bonilla C, Lewis SJ, Rowlands M-A, Gaunt TR, Smith GD, Gunnell D, Palmer T, Donovan JL, Hamdy FC, Neal DE et al..  2016.  Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.. International journal of cancer. 139(7):1520-1533. Abstract
Brunner C, Davies NM, Martin RM, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles G et al..  2017.  Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study.. International journal of cancer. 140(1):75-85. Abstract
Bull CJ, Bonilla C, Holly JM, Perks CM, Davies N, Haycock P, Yu OHY, Richards BJ, Eeles R, Easton D et al..  2016.  Blood lipids and prostate cancer: a Mendelian randomization analysis.. Cancer medicine. 5(6):1125-1136. Abstract
C
Christensen BG, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR et al..  2010.  Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses.. The Prostate. 70(7):735-44. Abstract
D
Davies NM, Gaunt TR, Lewis SJ, Holly J, Donovan JL, Hamdy FC, Kemp JP, Eeles R, Easton D, Kote-Jarai Z et al..  2015.  The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium.. Cancer causes & control : CCC. Abstract
E
Eeles RA, Al Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S et al..  2013.  Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.. Nature genetics. 45(4):385-91,391e1-2. Abstract
Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA et al..  2009.  Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.. Nature genetics. 41(10):1116-21. Abstract
Egbers L, Luedeke M, Rinckleb A, Kolb S, Wright JL, Maier C, Neuhouser ML, Stanford JL.  2015.  Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.. American journal of epidemiology. 181(9):706-13. Abstract
G
Geybels MS, Alumkal JJ, Luedeke M, Rinckleb A, Zhao S, Shui IM, Bibikova M, Klotzle B, van den Brandt PA, Ostrander EA et al..  2015.  Epigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.. Clinical epigenetics. 7:128. Abstract
Gusev A, Shi H, Kichaev G, Pomerantz M, Li F, Long HW, Ingles SA, Kittles RA, Strom SS, Rybicki BA et al..  2016.  Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation.. Nature communications. 7:10979. Abstract
I
Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, Musolf A, Li Q, Holzinger E, Karyadi D et al..  2016.  REVEL: an Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.. American journal of human genetics. 99(4):877-885. Abstract
J
Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Cannon-Albright LA, Camp NJ, Teerlink CC, Fitzgerald LM et al..  2012.  Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG).. Human genetics. 131(7):1095-1103. Abstract
K
Kar SP, Beesley J, Al Olama AA, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ et al..  2016.  Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.. Cancer discovery. 6(9):1052-1067. Abstract
Khankari NK, Murff HJ, Zeng C, Wen W, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K et al..  2016.  Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium.. British journal of cancer. Abstract
Kote-Jarai Z, Easton DF, Stanford JL, Ostrander EA, Schleutker J, Ingles SA, Schaid D, Thibodeau S, Dörk T, Neal D et al..  2008.  Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 17(8):2052-61. Abstract
Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurnauth-Little S, Ross-Adams H, Al Olama AA, Benlloch S, Halim S et al..  2013.  Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.. Human molecular genetics. Abstract
Kote-Jarai Z, Al Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Campa D, Riboli E, Key T, Gronberg H et al..  2011.  Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.. Nature genetics. 43(8):785-791. Abstract
L
Larson NB, McDonnell S, Albright LC, Teerlink C, Stanford J, Ostrander EA, Isaacs WB, Xu J, Cooney KA, Lange E et al..  2017.  gsSKAT: Rapid gene set analysis and multiple testing correction for rare-variant association studies using weighted linear kernels.. Genetic epidemiology. Abstract
Larson NB, McDonnell S, Albright LC, Teerlink C, Stanford J, Ostrander EA, Isaacs WB, Xu J, Cooney KA, Lange E et al..  2016.  Post hoc Analysis for Detecting Individual Rare Variant Risk Associations Using Probit Regression Bayesian Variable Selection Methods in Case-Control Sequencing Studies.. Genetic epidemiology. 40(6):461-469. Abstract